[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507256":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":27,"locations":36,"responsibleParty":99,"collaborators":32,"id":101,"slug":32,"hasResults":102,"nctId":103,"briefTitle":104,"officialTitle":104,"acronym":32,"eligibilityCriteria":105,"healthyVolunteers":106,"sex":107,"minAge":108,"maxAge":32,"enrollmentInfo":109,"targetDuration":32,"studyType":112,"phases":113,"briefSummary":115,"conditions":116,"keywords":32,"overallStatus":51,"whyStopped":32,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":127},{"fullName":5,"class":6},"Myra Vision Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Investigational Device Arm","EXPERIMENTAL","Subjects will receive a Calibreye glaucoma device (permanent implant)",[13],"Device: Calibreye System",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Calibreye System","Implantation of a glaucoma device to reduce intraocular pressure",[9],[21],"Glaucoma device, Glaucoma implant, Aqueous Shunt",[23],{"name":24,"affiliation":25,"role":26},"Keith Barton, MD","Moorfields Eye Hospital NHS Foundation Trust","STUDY_CHAIR",[28,34],{"name":29,"role":30,"phone":31,"phoneExt":32,"email":33},"Shienal Patel","CONTACT","14085602500",null,"info@myravision.com",{"name":35,"role":30,"phone":31,"phoneExt":32,"email":33},"Michelle Tran",[37,49,67,83],{"facility":38,"status":39,"city":40,"state":32,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":32},"Dr. Agarwal's Eye Hospital Ltd.","ACTIVE_NOT_RECRUITING","Chennai","600018","India",{"type":44,"coordinates":45},"Point",[46,47],80.27847,13.08784,{"lat":47,"lon":46},{"facility":50,"status":51,"city":52,"state":32,"zip":32,"country":53,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Centro Oftalmologico de Chihuahua","RECRUITING","Chihuahua City","Mexico",{"type":44,"coordinates":55},[56,57],-106.08889,28.63528,{"lat":57,"lon":56},[60,64],{"name":61,"role":30,"phone":62,"phoneExt":32,"email":63},"Mayra Salinas","52 61 4364 7898","mayra_dj@hotmail.com",{"name":65,"role":66,"phone":32,"phoneExt":32,"email":32},"Ana Cristina Luna, MD","PRINCIPAL_INVESTIGATOR",{"facility":68,"status":51,"city":69,"state":32,"zip":70,"country":53,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Oftalmología Láser de Puebla S.C.","Puebla City","72540",{"type":44,"coordinates":72},[73,74],-98.20723,19.04778,{"lat":74,"lon":73},[77,81],{"name":78,"role":30,"phone":79,"phoneExt":32,"email":80},"Aimee Hernandez","(22) 2257-0970","aimeehdz20@gmail.com",{"name":82,"role":66,"phone":32,"phoneExt":32,"email":32},"Gabriel Salomón Lazcano Gómez, MD",{"facility":84,"status":51,"city":85,"state":32,"zip":32,"country":86,"cosmosGeoPoint":87,"geoPoint":91,"contacts":92},"Panama Eye Center","Panama City","Panama",{"type":44,"coordinates":88},[89,90],-79.51973,8.9936,{"lat":90,"lon":89},[93,97],{"name":94,"role":30,"phone":95,"phoneExt":32,"email":96},"Idabel Orillac","+507 269 7475","idabelo28@gmail.com",{"name":98,"role":66,"phone":32,"phoneExt":32,"email":32},"Lautaro Vera, MD",{"type":100,"investigatorFullName":32,"investigatorTitle":32,"investigatorAffiliation":32,"oldNameTitle":32,"oldOrganization":32},"SPONSOR","100507256",false,"NCT05885022","Feasibility Clinical Evaluation of the Calibreye System","Inclusion Criteria:\n\n* Open angle, pseudoexfoliative or pigmentary glaucoma\n* IOP at preoperative visit of ≥ 18mmHg and ≤ 45mmHg\n* Visual field mean deviation score of -3dB or worse\n* Area of healthy, free and mobile conjunctiva in the target quadrant\n* Shaffer angle grade ≥ 3 in the target quadrant\n\nExclusion Criteria:\n\n* Angle closure glaucoma\n* Congenital, neovascular or other secondary glaucomas\n* Previous intraocular surgery (with the exception of laser trabeculoplasty or uncomplicated phacoemulsification with IOL occurring \\> 3 months prior to the preoperative visit)\n* Previous glaucoma shunt\u002Fvalve in the target quadrant\n* Clinically significant inflammation or infection in the study eye within 30 days prior to the preoperative visit\n* History of corneal surgery, corneal opacities or corneal disease\n* Active diabetic retinopathy",true,"ALL","18 Years",{"count":110,"type":111},60,"ESTIMATED","INTERVENTIONAL",[114],"NA","To evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.",[117],"Glaucoma, Open-Angle","2025-12-08",{"date":120,"type":121},"2025-12-15","ACTUAL",{"date":123,"type":121},"2023-05-31",{"date":125,"type":111},"2028-12",{"name":5,"class":6},4]